Prostaglandin E1 in the prophylaxis of renal dysfunction induced by contrast media;Prostaglandin E1 zur prophylaxe kontrastmittelinduzierter nierenfunktionsstorungen

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 170, Issue 6, 1999, Pages 557-563

  Koch, Jens Albrecht ^a   Sketch, M ^c   Brinker, J ^c   Bernink, P J ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MARTINI HOSPITAL   (Netherlands)

^c NONE

Author keywords

Contrast media; Nephroprotection; Prostaglandin E1; Renal dysfunction

Indexed keywords

CONTRAST MEDIUM; PLACEBO; PROSTAGLANDIN E1; CREATININE; VASODILATOR AGENT;

ACUTE KIDNEY FAILURE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFICACY; DRUG SAFETY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; ADULT; BLOOD; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; FEMALE; KIDNEY FUNCTION TEST; MALE; MULTICENTER STUDY; PILOT STUDY; PREMEDICATION; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALPROSTADIL; CONTRAST MEDIA; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; MALE; PILOT PROJECTS; PREMEDICATION; RADIOGRAPHY; VASODILATOR AGENTS;

EID: 0033147181     PISSN: 09366652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Conlon PJ, Schwab SJ: Time to abandon nonionic contrast? (Editorial). J Am Soc Nephrol 1994; 5: 123-124
2. Brezis M, Epstein FH: A closer look at radiocontrast induced nephropathy. N Engl J Med 1989; 320: 179-181
3. Morcos SK, Epstein FH, Haylor J, Dobrota M: Aspects of contrast media nephrotoxicity. Eur J Radiol 1996; 23: 178-184
4. Barrett BJ: Contrast nephrotoxicity. J Am Soc Nephrol 1994; 5: 125-137
5. Tommaso CL: Contrast-induced nephrotoxicity in patients undergoing cardiac catheterization. Cath and Cardiovasc Diagn 1994; 31: 316-321
6. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality. A cohort Analysis. JAMA 1996; 275: 1489-1494
7. Levy EM: The effect of ARF on duration of hospitalization. J Am Soc Nephrol 1996; 7: 1392
8. Heyman SN, Rosen S, Brezis M: Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney. Exp Nephrol 1994; 2: 153-157
9. Thadani R, Pascual M, Bonventre JV: Acute renal failure. N Engl J Med 1996; 334: 1448-1460
10. Cantley LG, Spokes K, Clark B, McMahon EG, Carter J, Epstein FH: Role of endothelin and prostaglandins in radio-contrast-induced renal artery constriction. Kidney Int 1993; 44: 1217-1223
11. 1 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J Biol Chem 1994; 269: 11938-11944
12. Ruetten H, Ney P, Thiemermann C: E-type prostaglandins inhibit the synthesis of endothelin-1 by endothelial cells in culture. Prostagl Leukotr Essent Fatty Acids 1996; 55 (Suppl1): 123
13. Paller MS, Manivel JC: Prostaglandins protect kidneys against ischemic and toxic injury by a cellular effect. Kidney Int 1992; 42: 1345-1354
14. Barrett BJ, Parfrey PS, Vavsour HM, McDonald J, Kent G, Hofferton D, O'Dea F, Stone E, Reddy R, McManamon PJ: Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992; 41: 1274-1279
15. Porter GA: Contrast-associated nephropathy: presentation, pathophysiology and management. Miner Electrolyte Metab 1994; 20: 232-243
16. Rudnick MR, Berns JS, Cohen RM, Goldfarb S: Contrast media-associated nephrotoxicity. Curr Opin Nephrol Hypertens 1996; 5: 127-133
17. Barrett BJ, Pardrey PS: Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 1994; 331:1449-1450
18. Lautin EM, Freemann NJ, Schoenfeld AH: Radiocontrast-associated renal dysfunction: Incidence and risk factors. Am J Roentgenol 1991; 157: 49-58
19. Rich MW, Crecelius CA: Incidence, risk factors and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age and older. A prospective study. Arch Intern Med 1990; 150: 1237-1242
20. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB: Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The lohexed Cooperative Study. Kidney Int 1995; 47: 254-261
21. Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC: Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986; 104: 501-504
22. Delmas PD: Non-steroidal anti-inflammatory drugs and renal function. Br J Rheumatol 1995; 34: 25-28
23. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ: Contrast material induced renal failure in patients with diabetes mellitus, renal insufficiency or both. N Engl J Med 1989; 320: 143-149
24. Solomon R, Werner C, Mann D, D'Elia J, Silva P: Effects of saline, mannitol and furosemide to prevent acute decrease in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-1420
25. Perrone RD, Madias NE, Levey AS: Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38 (10): 1933-1953
26. Isles CG, Paterson JR: Serum creatinine and urea: make the most of these simple test. Br J Hosp Med 1996; 55: 513-516
27. Cronin RE: Radiocontrast media-induced acute renal failure. In: Schrier RW, Gottschalk CW (Hrsg). Diseases of the kidney. Boston: Little, Brown & Co. 1993: 1187-1198
28. Winkler UH, Park JW, Weber S, Kothe A, Schnitker J, Behrends-Steins B, Albring M: Aktivierung von Blutgerinnung und Fibrinolyse nach Angiokardiographie mit ionischem und nichtionischem Kontrastmittel. Fortschr Röntgenstr 1997; 166: 539-543
29. Grönewaller EF, Wahl HG, Kehlbach R, Rodemann HP, Claussen CD, Duda SH: Stabilität jodhaltiger Röntgenkontrasmittel unter UV-Laser-Bestrahlung und Toxizität der Photoprodukte. Fortschr Röntgenstr 1998; 169: 537-541
30. Liebl R, Krämer B: Komplikationen nach Applikation von Röntgen-Kontrastmitteln bei Risikopatienten. Dtsch med Wschr 1996; 121: 1475-1479
31. 1 on renal function after cardiac surgery involving cardiopulmonary bypass. Prostagl Leukotr Essent Fatty Acids 1993; 49 627-631
32. Shindo H, Tawata M, Yokomori N, Hosaka Y, Ohtaka M, Onaya T: Iloprost decreases urinary albumin excretion rate in patients with diabetic nephropathy. Diabetes Res and Clin Practice 1993; 21: 115-122